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We have recently shown that the level of cell surface expression of envelope glycoproteins derived from various human
immunodeficiency virus type 1 (HIV-1) primary isolates (PI) was lower than those of envelope glycoproteins derived from
T-cell laboratory-adapted (TCLA) HIV-1 (D. Brand et al., 2000, Virology 271, 350–362). We investigated this phenomenon by
comparing the cell surface expression of chimeric envelope glycoproteins constructed by swapping the gp120 surface and
gp41 transmembrane glycoproteins of the TCLA HIV-1MN and the PI HIV-1133, HIV-1G365, or HIV-1EFRA. We found that each
chimeric envelope construct had a cell surface-specific pattern of expression similar to that of the parental envelope
glycoproteins corresponding to the gp41. Thus, the difference in cell surface expression observed between TCLA viruses and
various PI is probably due to a signal located in gp41. Identification of this signal may be important for the design of PI
envelope-derived immunogens and may increase our understanding of the mechanisms by which HIV-1 escapes from the
immune system. © 2001 Academic Press
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ciency virus type 1 (HIV-1) mediate the entry of the virus
into cells and are major targets of the cellular and hu-
moral immune response (Hunter and Swanstrom, 1990).
Indeed, HIV-1 envelope glycoproteins induce the produc-
tion of neutralizing antibodies that are effective against
the virus both in vitro and in vivo (Burton, 1997; Montefiori
nd Evans, 1999; Mascola et al., 2000; Baba et al., 2000).
These envelope glycoproteins are synthesized in the
rough endoplasmic reticulum as precursors. The precur-
sors are processed during exportation via the exocytic
pathway, to yield a surface subunit, gp120, noncovalently
attached to a transmembrane subunit, gp41, consisting of
an ectodomain, a single membrane-spanning domain,
and a long intracytoplasmic domain (Gabuzda et al.,
1992). This complex is incorporated into virions during
virus budding from the plasma membrane.
We recently studied the antigenic properties of several
HIV-1 envelope glycoproteins of the B subtype expressed
in the Semliki Forest virus (SFV) system (Brand et al.,
2000). These envelope glycoproteins were derived from
primary isolates (PI) (HIV-1BX08, HIV-1CHA, and HIV-1133) or
rom T-cell laboratory-adapted (TCLA) strains (HIV-1HXB2
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136and HIV-1MN). Cytometric analysis showed that envelope
glycoproteins of the three PI were less exposed at the
cell surface than those of the two TCLA viruses, despite
similar levels of overall production in cells. Since we first
reported this low level of cell surface exposure of PI
HIV-1BX08, HIV-1CHA, and HIV-1133 envelope glycoproteins
Brand et al., 2000), we have cloned other PI env gene
equences from various HIV-1 subtypes and expressed
hem in the SFV system (HIV-1A324, HIV-1AKON, HIV-1CMBA,
HIV-1DGOB, HIV-1EFRA, HIV-1FGIL, and HIV-1G365). In these
studies, low levels of cell surface expression of the PI
envelope glycoproteins were observed for most, but not
all, of the PI (Lemiale et al., submitted for publication).
Indeed, although the envelope glycoproteins of PI HIV-
1A324 and HIV-1EFRA were detected in large amounts at the
cell surface, the envelope glycoproteins of PI HIV-1AKON,
IV-1CMBA, HIV-1DGOB, HIV-1FGIL, and HIV-1G365 displayed
lower levels of cell surface expression, as previously
observed with PI HIV-1BX08, HIV-1CHA, and HIV-1133.
Investigation of this unexplained phenomenon may be
f importance for the development of vaccination ap-
roaches using PI envelopes as immunogens. The iden-
ification of a putative signal responsible for the weak
ell surface expression of most of the PI envelope gly-
oproteins might also increase our understanding of the
echanisms by which HIV-1 escapes from the immune
ystem.
Intracellular retention or retrieval signals have been
dentified in the transmembrane or cytoplasmic domains
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137CELL SURFACE EXPRESSION OF HIV-1 ENVELOPE GLYCOPROTEINSof envelope glycoproteins in various viral models (La-
branche et al., 1995; Andersson et al., 1997; Cocquerel et
l., 1998; Oeffner et al., 1999; Berlioz-Torrent et al., 1999).
In this study, we investigated whether the differences
observed in cell trafficking were due to the gp41 of HIV-1
primary isolates. In the first part of our study, two chi-
meric genes encoding the gp120133-gp41MN and the
p120MN-gp41133 envelope glycoproteins were con-
tructed by swapping the gp120 and gp41 sequences of
he TCLA HIV-1MN and the PI HIV-1133, which has the
owest level of envelope glycoprotein cell surface ex-
ression of all our PI. The levels of proteins on the cell
urface were compared with those of the parental enve-
FIG. 1. Analysis of two clones of the chimeric gp120133-gp41MN enve
clone 1; b, gp120133-gp41MN clone 2; c, 133; d, MN; e, mock) and cytom
IV-1133 and the TCLA strain HIV-1MN. Envelopes were tested against a
ncoding b-galactosidase. MFI, mean fluorescence intensity.ope glycoproteins. In the second part of our study, we
onducted a similar analysis of cell surface expressionsing two other chimeric genes encoding the gp120MN-
gp41G365 and the gp120MN-gp41EFRA envelope glycopro-
teins. The gp41G365 and gp41EFRA were derived from two PI
envelope glycoproteins with low and high levels of cell
surface expression, respectively.
RESULTS
Expression of the chimeric genes encoding the
gp120133-gp41MN envelope glycoproteins (Fig. 1)
Radioimmunoprecipitation analyses (Fig. 1A) showed
that the molecular masses of the parental and chimeric
envelope glycoproteins were similar, suggesting that the
ycoproteins by radioimmunoprecipitation (A; lanes a, gp120133-gp41MN
) and comparison with the parental envelope glycoproteins of the PI
f sera from HIV-1-infected patients. Mock: cells transfected with RNAlope gl
etry (Bchimeric proteins encoded by the two clones were effi-
ciently glycosylated. Processing of the gp120133-gp41MN
H pool o
e
138 LEBIGOT ET AL.chimeric envelope glycoproteins encoded by the two
clones was also efficient, as for the parental 133 and MN
envelope glycoproteins. Indeed, gp120 glycoproteins
were released into the cell supernatants for both paren-
tal and chimeric proteins, indicating that the gp160 pre-
cursor was correctly cleaved.
Flow cytometry (Fig. 1B) confirmed our previous report
showing that the envelope glycoproteins of PI such as
HIV-1133 were less strongly expressed at the cell surface
than those of a TCLA strain such as HIV-1MN. In addition,
the amount of gp120133-gp41MN chimeric envelope glyco-
proteins present on the cell surface was similar to that of
the parental MN glycoproteins. This was demonstrated
by similarity in the distribution of these envelope glyco-
FIG. 2. Analysis of two clones of the chimeric gp120MN-gp41133 enve
clone 1; b, gp120MN-gp41133 clone 2; c, 133; d, MN; e, mock) and cytom
IV-1133 and the TCLA strain HIV-1MN. Envelopes were tested against a
ncoding b-galactosidase. MFI, mean fluorescence intensity.proteins and by the mean fluorescence intensity, deter-
mined with Cellquest software, which was over 39 forboth the chimeric and the parental MN envelope glyco-
proteins, whereas it was only 24 for the parental 133
envelope glycoproteins.
Expression of the chimeric genes encoding the
gp120MN-gp41133 envelope glycoproteins (Fig. 2)
Radioimmunoprecipitation analyses showed that the
two chimeric genes encoded gp120MN-gp41133 envelope
glycoproteins of the expected molecular mass, which
were efficiently processed to yield the gp120 and gp41
subunits (Fig. 2A).
Flow cytometry (Fig. 2B) showed that the amount
of gp120MN-gp41133 chimeric envelope glycoproteins
ycoproteins by radioimmunoprecipitation (A; lanes a, gp120MN-gp41133
) and comparison with the parental envelope glycoproteins of the PI
f sera from HIV-1-infected patients. Mock: cells transfected with RNAlope gl
etry (Bpresent on the cell surface was similar to that of the
parental 133 envelope glycoproteins. This was demon-
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139CELL SURFACE EXPRESSION OF HIV-1 ENVELOPE GLYCOPROTEINSstrated by the similarity in distribution of these envelope
glycoproteins and by the mean fluorescence intensity,
which was below 28 for the chimeric and parental 133
envelope glycoproteins and about 46 for the parental MN
envelope glycoproteins.
Expression of the chimeric genes encoding the
gp120MN-gp41G365 and gp120MN-gp41EFRA envelope
lycoproteins (Fig. 3)
Flow cytometry (Fig. 3) confirmed the results obtained
ith the chimeric envelope glycoproteins gp120MN-
gp41133, showing that the gp41 of a PI expressed at a low
evel on the cell surface can reduce the amount of het-
rologous envelope glycoproteins present on the cell
urface. Indeed, the chimeric envelope glycoproteins
p120MN-gp41G365 were expressed at a low level on the
ell surface and showed a cell surface-specific pattern of
xpression similar to the parental envelope glycoprotein
365. This was demonstrated by the similarity in distri-
ution of these envelope glycoproteins and by the mean
luorescence intensity, determined with Cellquest soft-
are, which was no greater than 31 for both the chimeric
nd the parental G365 envelope glycoproteins and about
FIG. 3. Analysis of two clones of the chimeric gp120MN-gp41G365 and
the parental envelope glycoproteins of the PI HIV-1G365 and HIV-1EFRA. En
ells transfected with RNA encoding b-galactosidase. MFI, mean fluor5 for the parental MN envelope glycoproteins. Flow
ytometry (Fig. 3) also showed that the gp41EFRA derived
a
sfrom the envelope glycoproteins of a PI expressed at a
high level on the cell surface resulted in the maintenance
of a high level of cell surface expression of the gp120MN,
imilar to that of the parental EFRA envelope glycopro-
eins. This was demonstrated by the similarity in distri-
ution of these envelope glycoproteins and by the mean
luorescence intensity, determined with Cellquest soft-
are, which was over 38 for both the chimeric and the
arental EFRA envelope glycoproteins.
Radioimmunoprecipitation analyses showed that the
olecular masses of the parental and chimeric envelope
lycoproteins were similar, suggesting that the gp120MN-
p41G365 and gp120MN-gp41EFRA chimeric proteins were
efficiently glycosylated (data not shown). Processing of
the gp120MN-gp41G365 and gp120MN-gp41EFRA chimeric en-
elope glycoproteins was also efficient, as for the paren-
al G365 and EFRA envelope glycoproteins (data not
hown).
DISCUSSION
Our recent studies with env genes cloned from various
IV-1 isolates and expressed with the SFV system
howed that the envelope glycoproteins of most, but not
N-gp41EFRA envelope glycoproteins by cytometry and comparison with
were tested against a pool of sera from HIV-1-infected patients. Mock:
e intensity.gp120Mll, of the PI were present in smaller amounts on the cell
urface than were those of TCLA viruses (Brand et al.,
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140 LEBIGOT ET AL.2000; Lemiale et al., submitted for publication). This low
level of cell surface expression was not due to differ-
ences in the total expression in cells of envelope glyco-
proteins from PI and TCLA strains or to the cell type used
(Brand et al., 2000). As similar levels of PI and TCLA
envelope glycoproteins were synthesized, we suggested
that the intracellular trafficking of some PI envelope gly-
coproteins might differ, resulting in low levels of cell
surface expression.
The results presented herein for the chimeric proteins
show that the gp41 transmembrane glycoproteins de-
rived from PI with low-level envelope glycoprotein ex-
pression at the cell surface were able to decrease the
amounts not only of homologous, but also of heterolo-
gous, envelope glycoproteins present on the cell surface.
This was first suggested with the gp120133-gp41MN chi-
meric envelope glycoproteins, which presented a cell
surface-specific pattern of expression similar to the pa-
rental envelope glycoproteins of the TCLA strain HIV-1MN.
onversely, the gp120MN-gp41133 chimeric envelope gly-
oproteins were expressed at a low level at the cell
urface, as observed for the parental envelope glyco-
roteins of the PI HIV-1133. To confirm these observations
with other PI envelope sequences, we constructed two
new chimeric envelope glycoproteins, gp120MN-gp41G365
and gp120MN-gp41EFRA. The gp41G365 and gp41EFRA glyco-
roteins were derived from parental envelope glycopro-
eins expressed at low and high levels, respectively, at
he cell surface. As expected, gp41G365 reduced the cell
urface expression of gp120MN to a level similar to that of
the G365 parental envelope glycoproteins, thereby con-
firming the result obtained with gp41133. Conversely,
gp41EFRA maintained the cell surface expression of
p120MN at a level similar to that of the parental EFRA
envelope glycoproteins. Interestingly, this result shows
that a gp41 derived from a PI envelope glycoprotein
highly expressed on the cell surface behaved similarly, in
terms of cell surface expression, to a gp41 derived from
a TCLA virus.
In the SFV expression system, the recombinant RNAs
were strictly similar except for the env sequences. Thus,
the low level of cell surface expression of envelope
glycoproteins derived from PI such as HIV-1133 or HIV-
G365 can only be due to the amino acid sequence of the
ctodomain, the membrane-spanning domain, or the cy-
oplasmic tail of their gp41 transmembrane glycopro-
eins. The membrane-spanning domain and the ectodo-
ain sequences of gp41133, gp41G365, and gp41 derived
from other PI with low-level envelope glycoprotein ex-
pression at the cell surface (HIV-1CHA, HIV-1BX08, HIV-1AKON,
HIV-1CMBA, HIV-1DGOB, HIV-1FGIL) displayed minor differ-
ences from the TCLA strains HIV-1MN and HIV-1HXB2 or PI
such as HIV-1EFRA (Lemiale et al., submitted for publica-
tion). As most membrane-associated cell proteins have
information in their cytosolic tail that determines the
subcellular location of the protein (Nilsson and Warren,
b1994; Kaiser and Ferro-Novick, 1998), we paid particular
attention to the sequences of the gp41 cytosolic do-
mains. None of the previously identified signals, such as
the endoplasmic reticulum K(X)KXX (K, Lys; X, any amino
acid) or the trans-Golgi network YQRL (Y, Tyr; Q, Glu; R,
Arg; L, Leu) retention signals (Nilsson and Warren, 1994)
were present, either in the sequences of gp41133 and
gp41G365 or in the sequences of gp41 derived from other
I with low-level envelope glycoprotein expression at the
ell surface (HIV-1CHA, HIV-1BX08, HIV-1AKON, HIV-1CMBA, HIV-
DGOB, HIV-1FGIL). Possible retention in the ER can proba-
bly be excluded because retention in this compartment
would abolish cleavage of the gp160 precursor, as dem-
onstrated experimentally elsewhere (Salzwedel et al.,
1998). Our radioimmunoprecipitation assays showed that
the parental and chimeric envelope glycoproteins were
proteolytically processed to yield gp120 in the culture
supernatants. In addition, functional investigations,
based on the use of recombinant viruses, showed that all
the parental envelope glycoproteins and chimeric enve-
lope glycoproteins derived from the PI HIV-1133 and TCLA
IV-1MN allowed viral entry (Dr. Fabrizio Mammano, per-
sonal communication).
Alternatively, greater exportation of TCLA strains HIV-
1MN and HIV-1HXB2 or PI HIV-1EFRA envelope glycoproteins
o the cell surface may account for the difference be-
ween these proteins and those derived from PI with
ow-level envelope glycoprotein expression at the cell
urface. However, export signals such as NXE (N, Asn; X,
ny amino acid; E, Glu) and FF (F, Phe), which have been
eported to favor transport through the secretory path-
ay (Kaiser and Ferro-Novick, 1998), are not present in
he cytosolic tail of the gp41 of TCLA strains or PI HIV-
EFRA. It is also possible that PI envelope glycoproteins
re more rapidly reinternalized by endocytosis than
hose of TCLA viruses. Rapid internalization involves the
ecruitment of plasma membrane proteins to clathrin-
oated pits. This process is mediated by interaction of
he endocytic signals found in the cytosolic domains of
he proteins with the clathrin-associated adaptor com-
lex AP-2 (Ohno et al., 1995). Such endocytic signals
ave been found in the cytosolic domain of HIV-1 glyco-
rotein and consist of a YXXØ Tyr-based motif (Y, Tyr; X,
ny amino acid; Ø, Leu, Ile, Phe, Val, or Met) (Sauter et
l., 1996). The two Tyr-based motifs present in the HIV-1
p41 cytosolic domain at Y712 and Y768 are highly con-
erved among HIV-1 isolates, including our studied TCLA
nd PI strains. However, additional determinants distal to
he YXXØ motif may be also involved in this mechanism
Berlioz-Torrent et al., 1999). Two retrieval motifs, is1 and
s2, have recently been identified (Bultmann et al., 2001),
ut these signals are also conserved in our PI and TCLA
iruses. It is possible that other, as yet unidentified re-
rieval motifs, differ between our PI and TCLA viruses,
ut this remains to be determined.
We are currently trying to identify the gp41 amino acid
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141CELL SURFACE EXPRESSION OF HIV-1 ENVELOPE GLYCOPROTEINSdomains involved in the difference in intracellular traf-
ficking between TCLA and some PI envelope glycopro-
teins, by producing new chimeric proteins involving the
gp41133 ectodomain and membrane-spanning and cyto-
solic domains and by site-directed mutagenesis. The
identification of these motifs may increase our under-
standing of the mechanisms by which the virus estab-
lishes a persistent infection in vivo. Indeed, a signal in
gp41 reducing the amount of PI envelope glycoproteins
on the surface of infected cells may limit the suscepti-
bility of these cells to humoral and cellular immune
responses. More importantly, these ongoing studies may
be important for future vaccination strategies based on
the use of PI envelope glycoproteins as immunogens.
We have already demonstrated the poor immunogenicity
of various PI envelope glycoproteins in terms of their lack
of ability to induce neutralizing antibodies (Brand et al.,
2000). These disappointing results were attributed to the
possible weak cell surface expression of PI glycopro-
teins in vivo, using recombinant SFV particles as vaccine
vectors. The abolition by mutation of a putative retention
and/or reinternalization signal in the gp41 of various PI
strains might facilitate the design of optimized PI enve-
lope glycoproteins for future vaccination strategies.
MATERIALS AND METHODS
Construction of chimeric env genes
The four chimeric env genes were constructed using
env sequences amplified by PCR from pSFV-env MN,
pSFV-env 133, pSFV-env EFRA, and pSFV-env G365
(Brand et al., 2000; Lemiale et al., submitted for publica-
tion). For construction of the gp120133-gp41MN chimeric
nvelope gene, the gp120 gene of PI HIV-1133 was am-
plified with the primers 59 AGGATCCGAAGACAGGCAC-
CATGAGAGTGGAGGAGATCA 39 and 59 TCTCTCTGCAC-
CACGCGTCTCCTTGC 39, and the gp41 of the TCLA
strain HIV-1MN was amplified with the primers 59 GCAAA-
GAGACGCGTGGTGCAGAGAGA 39 and 59 GGGATC-
CATCTTATAGCAAAGCCCTTTC 39. These PCR products
were inserted into pCR2.1 using the TOPO TA cloning
system (Invitrogen, Carlsbad, CA). The primers were de-
signed to generate the following specific restriction sites:
a BamHI site at the 59 end of the gp120133 gene and at the
9 end of the gp41MN gene and a MluI site at the 39 end
of the gp120133 gene and at the 59 end of the gp41MN
gene. The gp120133 gene was inserted upstream of the
gp41MN gene, to obtain the complete chimeric envelope
ene. The expression vector pSFV-gp120133-gp41MN was
then constructed by inserting the chimeric env gene into
the BamHI site in the linker of the pSFV1 vector (Life
Technologies, Rockville, MD). The chimeric envelope
gp120MN-gp41133, gp120MN-gp41EFRA, and gp120MN-gp41G365
genes were constructed in a similar fashion. The gp120
gene of the TCLA strain HIV-1MN was amplified with the
primers 59 AGGATCCGAAGACAGGCACCATGAGAG 39nd 59 TCTCTCTGCACCACGCGTCTCTTTGC 39, the gp41
ene of the PI HIV-1133 was amplified with the primers 59
GCAAGGAGACGCGTGGTGCAGAGAGA 39 and 59 GG-
GATCCATCTTATAGCAAAGCCCTTTC 39, the gp41 gene
of the PI HIV-1EFRA was amplified with the primers 59
CAAAGAGACGCGTGGTGGAGAGAGA 39 and 59 GG-
ATCCATGTTATAGCAAAGCCCTTTC 39, and the gp41
ene of the PI HIV-1G365 was amplified with the primers 59
CAAGGAGACGCGTGGTGGGGAGAGA 39 and 59 GG-
GATCCATGTTATTGCAAAGCTCTTTC 39. The expression
vectors pSFV-gp120MN-gp41133, pSFV-gp120MN-gp41EFRA,
and pSFV-gp120MN-gp41G365 were then constructed by
nserting the chimeric env gene into the BamHI site in the
inker of the pSFV1 vector. Two clones were constructed
or each chimera.
reparation of recombinant SFV RNA
Recombinant RNAs (rRNA) encoding the chimeric en-
elope glycoproteins were synthesized using the recom-
inant vectors pSFV-gp120133-gp41MN, pSFV-gp120MN-
p41133, pSFV-gp120MN-gp41EFRA, pSFV-gp120MN-gp41G365,
SFV-MN, pSFV-133, pSFV-EFRA, and pSFV-G365 as
emplates (Brand et al., 1998, 2000; Lemiale et al., sub-
itted for publication). For the control, recombinant RNA-
b-gal, encoding the b-galactosidase protein, was synthe-
sized using the expression vector pSFV3 (Life Technol-
ogies). The rRNAs were synthesized in vitro according to
the protocol provided by the manufacturer. The RNA
samples were then stored at 280°C until use.
Cell culture, metabolic labeling, and
immunoprecipitation
Baby hamster kidney (BHK-21) cells were grown in
GMEM (Life Technologies) supplemented with 5% fetal
calf serum and 2% phosphate tryptose. Cells (107 per
transfection) were electroporated (350 V, 750 mF) with 5
mg of each rRNA, plated in 75-cm2 tissue culture flasks,
and labeled in cysteine-free medium containing 5% heat-
inactivated FCS and 40 mCi of [35S]cysteine per milliliter.
The cells were incubated for 16 h at 37°C and lysed with
Nonidet P-40 buffer [0.5% Nonidet P-40, 0.5 M NaCl, 10
mM Tris–HCl (pH 7.5)]. Culture supernatants (800 ml/
reaction) and cell lysates (80 ml/reaction corresponding
to 3 3 105 cells) were immunoprecipitated with a pool of
era from HIV-1-infected individuals (5 ml/reaction). The
immunoprecipitated proteins were incubated with pro-
tein A-conjugated Sepharose CL4-B beads (Pharmacia,
Uppsala, Sweden; 8 mg/reaction) for 18 h at 4°C. They
were washed three times with Nonidet P-40 buffer, sep-
arated by electrophoresis in 10% SDS–polyacrylamide
gels, and detected by autoradiography.
Flow cytometry
7BHK-21 (10 per transfection) cells were electropo-
rated (350 V, 750 mF) with 5 mg of each rRNA and plated
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142 LEBIGOT ET AL.in 75-cm2 tissue culture flasks. The cells were incubated
or 16 h at 37°C, harvested, washed once in PBS, pel-
eted, and resuspended at a density of 106 cells per 100
ml in ice-cold PBS containing 2% bovine serum albumin
(PBS-BSA). Cell suspensions (100 ml) were incubated for
0 min at 4°C with a pool of sera from HIV-1-infected
ndividuals (0.5 ml/reaction). The cells were then washed
wice in ice-cold PBS-BSA and incubated for 30 min at
°C with a FITC-labeled anti-human IgG (Fab) conjugate
Cappel/ICN, Costa Mesa, CA) diluted 1:1500 in PBS-BSA
nd immediately analyzed in a Beckton–Dickinson FAC-
tar Plus flow cytometer (Beckton–Dickinson, San Jose,
A), using Cellquest software.
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